Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy.

Shadman M, Gauthier J, Hay KA, Voutsinas JM, Milano F, Li A, Hirayama AV, Sorror ML, Cherian S, Chen X, Cassaday RD, Till BG, Gopal AK, Sandmaier BM, Maloney DG, Turtle CJ.

Blood Adv. 2019 Oct 22;3(20):3062-3069. doi: 10.1182/bloodadvances.2019000593.

2.

Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation.

Wenger DS, Triplette M, Crothers K, Cheng GS, Hill JA, Milano F, Shahrir S, Schoch G, Vande Vusse LK.

Biol Blood Marrow Transplant. 2019 Oct 9. pii: S1083-8791(19)30654-8. doi: 10.1016/j.bbmt.2019.09.034. [Epub ahead of print]

PMID:
31605819
3.

CD34+ cell content of 126‚ÄČ341 cord blood units in the US inventory: implications for transplantation and banking.

Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, Politikos I, Shpall EJ, Scaradavou A, Dehn J.

Blood Adv. 2019 Apr 23;3(8):1267-1271. doi: 10.1182/bloodadvances.2018029157.

4.

The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia.

Keating AK, Langenhorst J, Wagner JE, Page KM, Veys P, Wynn RF, Stefanski H, Elfeky R, Giller R, Mitchell R, Milano F, O'Brien TA, Dahlberg A, Delaney C, Kurtzberg J, Verneris MR, Boelens JJ.

Blood Adv. 2019 Apr 9;3(7):1118-1128. doi: 10.1182/bloodadvances.2018025908.

5.

Improved Survival after Cord Blood Transplantation: Single-Center Experience in Pediatric Patients Over a 2-Decade Period.

Dahlberg A, Milano F.

Biol Blood Marrow Transplant. 2019 Apr;25(4):e117-e118. doi: 10.1016/j.bbmt.2019.02.010. Epub 2019 Feb 13. No abstract available.

PMID:
30771496
6.

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.

Elsawy M, Storer BE, Milano F, Sandmaier BM, Delaney C, Salit RB, Rashad AH, Woolfrey AE, Appelbaum FR, Storb R, Sorror ML.

Biol Blood Marrow Transplant. 2019 May;25(5):1045-1052. doi: 10.1016/j.bbmt.2018.11.030. Epub 2018 Nov 28.

PMID:
30500442
7.

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation.

Fatobene G, Storer BE, Salit RB, Lee SJ, Martin PJ, Cheng GS, Carpenter PA, Balgansuren G, Petersdorf EW, Delaney C, Sandmaier BM, Milano F, Flowers ME.

Haematologica. 2019 Apr;104(4):835-843. doi: 10.3324/haematol.2018.202754. Epub 2018 Nov 15.

8.

Hematopoietic Stem Cell Transplantation in the Era of Engineered Cell Therapy.

Appelbaum JS, Milano F.

Curr Hematol Malig Rep. 2018 Dec;13(6):484-493. doi: 10.1007/s11899-018-0476-4. Review.

PMID:
30280289
9.

Mutant NPM1 Maintains the Leukemic State through HOX Expression.

Brunetti L, Gundry MC, Sorcini D, Guzman AG, Huang YH, Ramabadran R, Gionfriddo I, Mezzasoma F, Milano F, Nabet B, Buckley DL, Kornblau SM, Lin CY, Sportoletti P, Martelli MP, Falini B, Goodell MA.

Cancer Cell. 2018 Sep 10;34(3):499-512.e9. doi: 10.1016/j.ccell.2018.08.005.

10.

Reply to Author.

Hill JA, Pergam SA, Boeckh M, Milano F.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2166. doi: 10.1016/j.bbmt.2018.06.030. Epub 2018 Jun 30. No abstract available.

11.

A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients.

Hill JA, Pergam SA, Cox E, Xie H, Leisenring WM, Boeckh M, Delaney C, Milano F.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2094-2100. doi: 10.1016/j.bbmt.2018.05.008. Epub 2018 May 16.

12.

Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Deeg HJ, Stevens EA, Salit RB, Ermoian RP, Fang M, Gyurkocza B, Sorror ML, Fatobene G, Baumgart J, Burroughs LM, Delaney C, Doney K, Egan DN, Flowers MED, Milano F, Radich JP, Scott BL, Sickle EJ, Wood BL, Yeung C, Storer BE.

Biol Blood Marrow Transplant. 2018 May;24(5):956-963. doi: 10.1016/j.bbmt.2017.12.785. Epub 2017 Dec 20.

13.

Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.

Bhattacharyya A, Hanafi LA, Sheih A, Golob JL, Srinivasan S, Boeckh MJ, Pergam SA, Mahmood S, Baker KK, Gooley TA, Milano F, Fredricks DN, Riddell SR, Turtle CJ.

Biol Blood Marrow Transplant. 2018 Feb;24(2):242-251. doi: 10.1016/j.bbmt.2017.10.003. Epub 2017 Oct 9.

14.

Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation.

Hill JA, Mayer BT, Xie H, Leisenring WM, Huang ML, Stevens-Ayers T, Milano F, Delaney C, Jerome KR, Zerr DM, Nichols G, Boeckh M, Schiffer JT.

Clin Infect Dis. 2018 Jan 18;66(3):368-375. doi: 10.1093/cid/cix804.

15.

Persistence of the losing cord blood unit following double cord blood transplantation: finding the unseen.

Milano F, Gammill H, Oliver DC, Kanaan SB, Nelson JL, Delaney C.

Blood. 2017 Sep 21;130(12):1480-1482. doi: 10.1182/blood-2017-06-788513. Epub 2017 Aug 1. No abstract available.

16.

Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, Horwitz M, Milano F, Olson A, Spellman S, Wagner JE, Delaney C, Shpall E.

Biol Blood Marrow Transplant. 2017 Jun;23(6):882-896. doi: 10.1016/j.bbmt.2017.03.006. Epub 2017 Mar 6. Review.

17.

The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.

Hill JA, Mayer BT, Xie H, Leisenring WM, Huang ML, Stevens-Ayers T, Milano F, Delaney C, Sorror ML, Sandmaier BM, Nichols G, Zerr DM, Jerome KR, Schiffer JT, Boeckh M.

Blood. 2017 Apr 20;129(16):2316-2325. doi: 10.1182/blood-2016-10-748426. Epub 2017 Feb 16.

18.

Notch-Expanded Murine Hematopoietic Stem and Progenitor Cells Mitigate Death from Lethal Radiation and Convey Immune Tolerance in Mismatched Recipients.

Milano F, Merriam F, Nicoud I, Li J, Gooley TA, Heimfeld S, Imren S, Delaney C.

Stem Cells Transl Med. 2017 Feb;6(2):566-575. doi: 10.5966/sctm.2016-0112. Epub 2016 Sep 13.

19.

Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation.

Salit RB, Oliver DC, Delaney C, Sorror ML, Milano F.

Biol Blood Marrow Transplant. 2017 Apr;23(4):654-658. doi: 10.1016/j.bbmt.2017.01.084. Epub 2017 Feb 9.

20.

Real Time Immunophenotyping of Leukocyte Subsets Early after Double Cord Blood Transplantation Predicts Graft Function.

Li J, Nicoud I, Blake J, Oliver D, Cox E, Heimfeld S, Milano F, Imren S, Delaney C.

Biol Blood Marrow Transplant. 2017 Mar;23(3):412-419. doi: 10.1016/j.bbmt.2016.12.625. Epub 2016 Dec 19.

Supplemental Content

Loading ...
Support Center